There is a farm in Maine where a woman grows cannabis outdoors, off-grid, on land certified organic by the state's own agricultural authority. She runs a two-person operation. Her plants see the sun. Her records are audited under USDA organic handling standards. She sells directly to patients who know her name. In nearly every meaningful sense, she is doing what the legalization movement promised cannabis could be.
In Augusta, the state capital, there are people who would like to make what she does either illegal or economically impossible. They have a contamination study, a governor who calls the program "the wild, wild West," a public health coalition of a dozen organizations, and a contract with METRC-the seed-to-sale tracking titan-behind them. They also have a regulator whose professional history runs through the same consulting orbit that helped bring the tracking software to Maine's adult-use market. The same man who helped shape the adult-use rules that made METRC mandatory now argues it should be imposed on a medical program that has functioned without it for twenty-six years.
The Program The Community Built
Maine has historically been progressive about weed. The state decriminalized possession in 1976. Voters approved medical cannabis by a 61.4% margin in 1999, making Maine the fifth legal medical state. What grew from that was a caregiver program, consisting of small cultivators growing for patients they knew personally, operating under the same kind of trust-based, record-keeping framework you'd find in Maine's shellfish, dairy or other agricultural industries.
The program expanded through fits and starts. A 2009 ballot initiative established a dispensary framework, initially capped at eight. In 2018, LD 1539 eliminated the list of qualifying conditions entirely-allowing physicians to solely use their professional criteria-and allowing caregivers to open retail storefronts, hire employees, and operate as full commercial businesses. In February 2019, Governor Mills created the Office of Cannabis Policy to "consolidate oversight." That June, Maine expanded reciprocity to allow visiting patients from other states to purchase simply by showing their home-state credential. The state now accepts medical credentials from 29 states plus Washington, D.C.


Photo courtesy of Maine-based Atlantic Farms
Lizzy Hayes is a registered caregiver in this program. She grows exclusively outdoors, off-grid, and her farm holds Clean Cannabis Certification from the Maine Organic Farmers and Gardeners Association, verifying compliance with USDA organic standards-including seed-to-sale tracking through audited records. She describes the program as one that developed slowly and organically, with tracking done through paper recordkeeping and testing required only to verify claims made on labeling. The regulators, she notes, already have statutory authority to audit-test operators and inspect both facilities and records.
The numbers tell you the market's own verdict. As of 2025, 112,547 patients were registered-roughly 8% of Maine's population, one of the highest per-capita rates in the country, nearly tripled from the 41,858 certifications that existed in 2017. The program supports 1,539 caregivers and over 5,000 employees. In 2021, medical cannabis generated $371 million in sales versus just $81 million for adult-use. Even in 2023, medical ($280 million) still outpaced recreational ($217 million). Year after year, Mainers with access to both programs have renewed their medical cards and chosen the caregiver market. OCP Director John Hudak himself admitted surprise, acknowledging that most people assumed medical would have been absorbed by adult-use by now, as has partially happened in many other states.
So, what's their secret?
Mark Barnett, founder and policy director of the Maine Craft Cannabis Association, operates a combined coffee shop and dispensary in Portland's Old Port. He frames what Maine has built in terms that should embarrass every other state program in the country.
"We have by far the highest quality regulatory environment for our medical cannabis program, as evidenced by the amazing number of participants, business participants in that program who are two hundred and fifty thousand dollars a year or less in total turnover. True craft businesses, true micro businesses, all the things that folks like to point out as what we should be supporting-Maine is already doing it and has been doing it since '99."


Photo courtesy of Maine-based Atlantic Farms
The smallest registration type allows cultivation of six plants-the most accessible entry point in any legal cannabis program in the country. The largest caregiver canopy caps at 500 square feet. Between those poles, an estimated 237 caregivers operate retail storefronts. According to the OCP's own 2025 annual report, administrative actions impacted just 1% of all registered caregivers, and the vast majority of violations were resolved through technical assistance rather than fines or revocations. In the language of agricultural regulation, that is a well-functioning program.
In the language of Maine's current governor, that's a problem.
Colorado Consultants
When Maine voters approved recreational cannabis in 2016 by a narrow 51% margin, the state hired a consulting group to draft the implementation framework. The group included Andrew Freedman, Colorado's first cannabis policy director; Lewis Koski, former director of Colorado's Marijuana Enforcement Division; and John Hudak, a senior fellow at the Brookings Institution. During the period Koski was contracted with Maine, he took a position at METRC-the biggest seed-to-sale tracking company in the US-where he now serves as Chief Strategy Officer. METRC's parent company is Franwell, Inc.
The adult-use program that was then deployed in Maine was heavily inspired by the one in Colorado, requiring METRC tracking and mandatory batch testing-the standard template that has been replicated as states adopt legal cannabis. Maine's medical program, by contrast, remained a grassroots industry with a low barrier to entry, treated more like other regulated agricultural sectors.
The adult-use rules that emerged included mandatory batch testing across seven analyte categories, and a compliance infrastructure that now costs licensees $40 per month plus RFID tag fees ($0.25 per package, $0.45 per plant), third-party integration software ($100–$500/month), and the less visible costs of dedicated compliance labor and system downtime. The state's original six-year METRC contract was at that time valued at $540,000. The medical program had none of this. It continued under its trip-ticket, transaction-log, and audit-inspection framework-a system that, as Hayes notes, records the date, time, location, registration numbers, and description of every cannabis transfer, and which she argues is sufficient to conduct a recall.



Photo by @thecuratorco.me at @artandcraft_can
"To get that passed at the last minute, they added municipal control of licensing. They kind of cracked down or doubled down on the thing that would eventually become METRC-which is the requirement for seed-to-sale tracking, which is kind of the Voldemort of the cannabis industry. No other industry has to deal with anything like that at all," says Barnett.
And he underlines that the cannabis community was not asked whether it supported those additions. That was a deal made at the last minute. Closed doors. And this then led to the attempt to transpose those same rules onto the medical program that had been working for two decades. Advocates responded by passing LD 1242, a bill that stripped the executive branch's ability to impose rules on the medical program without originating legislation through the full legislature, with public hearings and elected accountability. The OCP could no longer rewrite the medical program in the dark.
That shield held for years but it's now being eroded.
